Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms

被引：3

作者：

Patnaik, Mrinal M. ^{[1
]}

Zeidan, Amer M. ^{[2
,3
]}

Padron, Eric ^{[4
]}

Platzbecker, Uwe ^{[5
]}

Sallman, David A. ^{[4
]}

DeZern, Amy E. ^{[6
,7
]}

Bejar, Rafael ^{[8
]}

Sekeres, Mikkael ^{[9
]}

Taylor, Justin ^{[9
]}

Little, Richard F. ^{[10
]}

Bewersdorf, Jan P. ^{[11
]}

Kim, Tae Kon. ^{[12
]}

Kim, Nina ^{[10
]}

Hourigan, Christopher S. ^{[10
]}

Dela Porta, Matteo G. ^{[13
,14
]}

Stahl, Maximilian ^{[15
,16
]}

Steensma, David ^{[17
]}

Xu, Mina L. ^{[3
,18
,19
]}

Odenike, Olatoyosi ^{[20
]}

Carraway, Hetty ^{[21
]}

Fenaux, Pierre ^{[22
,23
]}

Nazha, Aziz ^{[24
]}

Komrokji, Rami ^{[4
]}

Loghavi, Sanam ^{[25
]}

Xie, Zhuoer ^{[4
]}

Hasserjian, Robert ^{[26
]}

Savona, Michael ^{[12
]}

Bennett, John M. ^{[27
]}

机构：

[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA

[2] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06510 USA

[3] Yale Canc Ctr, New Haven, CT USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA

[5] Univ Leipzig, Dept Hematol, Leipzig, Germany

[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Baltimore, MD USA

[7] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA

[8] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA USA

[9] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

[10] NCI, NIH, Bethesda, MD 20892 USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[12] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Hematol, Nashville, TN 37212 USA

[13] Humanitas Clin & Res Ctr, Milan, Italy

[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[15] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[16] Harvard Med Sch, Boston, MA 02115 USA

[17] Novartis Inst Blood Res, Boston, MA USA

[18] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA

[19] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA

[20] Univ Chicago Med, Hematol Oncol Sect, Chicago, IL USA

[21] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA

[22] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[23] Univ Paris Cite, Paris, France

[24] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA

[25] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[26] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[27] Univ Rochester, Med Ctr, Dept Med Pathol & Lab Med, Rochester, NY 14642 USA

来源：

LEUKEMIA | 2022年 / 36卷 / 12期

关键词：

HEALTH-ORGANIZATION CLASSIFICATION; REVISION; LEUKEMIA;

D O I：

10.1038/s41375-022-01754-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2934 / 2938

页数：5

共 50 条

[21] Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria*
Triguero, A.
Xicoy, B.
Zamora, L.
Jimenez, M. J.
Garcia, O.
Calabuig, M.
Diaz-Beya, M.
Arzuaga, J.
Ramos, F.
Medina, A.
Bernal, T.
Talarn, C.
Coll, R.
Collado, R.
Chen, T. Hua
Borras, J.
Brunet, S.
Marchante, I
Marco, V
Lopez-Cadenas, F.
Calbacho, M.
Simiele, A.
Cortes, M.
Cedena, M. T.
Pedreno, M.
Aguilar, C.
Pedro, C.
Fernandez, M.
Stoica, C.
Ribera, J. M.
Sanz, G.
LEUKEMIA RESEARCH, 2022, 116
[22] Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
Wan, Ziqi
Han, Bing
FRONTIERS IN ONCOLOGY, 2020, 10
[23] Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis
Sorigue, Marc
Arenillas, Leonor
Xicoy, Blanca
Andrade-Campos, Marcio
Navarro, Jose-Tomas
Ferrer, Ana
Zamora, Lurdes
Calvo, Xavier
LEUKEMIA RESEARCH, 2022, 112
[24] A RARE CASE OF MYELODYSPLASTIC/MYELOPROLIFERATIVE OVERLAP SYNDROME
Jagadeesan, Cindrel Tharumia
Varda, Bianca
Giclas, Hannah
Raj, Jaya
JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S206 - S206
[25] Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Xie, Wei
Chen, Zhining
Wang, So A.
Hu, Shimin
Li, Shaoying
Miranda, Roberto N.
Medeiros, L. Jeffrey
Tang, Guiling
LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2993 - 3001
[26] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Ulrike Bacher
Susanne Schnittger
Wolfgang Kern
Tamara Weiss
Torsten Haferlach
Claudia Haferlach
Annals of Hematology, 2009, 88 : 1207 - 1213
[27] Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
Fontana, Diletta
Elli, Elena M.
Pagni, Fabio
Piazza, Rocco
CANCERS, 2023, 15 (12)
[28] Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category
Bacher, Ulrike
Schnittger, Susanne
Kern, Wolfgang
Weiss, Tamara
Haferlach, Torsten
Haferlach, Claudia
ANNALS OF HEMATOLOGY, 2009, 88 (12) : 1207 - 1213
[29] Classification of myeloproliferative neoplasms and chronic myeloproliferative disorders
Kreipe, Hans H.
ONKOLOGE, 2019, 25 (11): : 957 - 970
[30] The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
Ragon, Brittany Knick
Savona, Michael R.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S37 - S42

← 1 2 3 4 5 →